CVS and Walgreens to Sell CBD Products!

On March 21st, CVS announced plans to begin selling over-the-counter topical CBD-infused products at more than 800 stores in 8 states: Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee. One week later on March 28th, Walgreens announced plans to begin selling over-the-counter topical CBD-infused products at nearly 1,500 stores in 9 states: Colorado, Illinois, Indiana, Kentucky, New Mexico, Oregon, South Carolina, Tennessee and Vermont. All together, CVS and Walgreens will be selling CBD-infused products in approximately 2,300 total stores across 12 different states.

CVS and Walgreens have a total of 19,360 stores across all 50 states plus the District of Columbia, Puerto Rico and U.S. Virgin Islands. 82% of Americans live within 10 miles of a CVS and 78% of Americans live within 5 miles of a Walgreens or one of their Duane Reade stores.

NIA's new #1 California CBD stock suggestion Alternate Health (CSE: AHG) is in the process of acquiring Blaine Labs, a 23-year old Southern California-based manufacturer and distributor of FDA-approved and cGMP-certified dermatological products. Last year, Blaine Labs generated revenue in excess of USD$14 million with net income of approximately USD$8 million. In August 2014, Blaine Labs announced in a press release that it had gained nationwide distribution to all 7,600+ CVS/pharmacy locations for its Revitaderm Psoriasis Treatment.

Today, CVS has 9,800+ locations and not only does Blaine Labs continue to distribute its Revitaderm Psoriasis Treatment to all CVS stores, but you can now find their Tineacide Antifungal Solution in all 9,800+ CVS stores as well! In fact, Walgreens is also selling their Tineacide Antifungal Solution in all 9,560 of their stores!

When AHG's acquisition of Blaine Labs closes in July, AHG will officially become the world's only CBD company with nationwide distribution to all CVS and Walgreens locations. In the upcoming weeks, we expect AHG and Blaine Labs to begin officially rolling out a proprietary line of CBD-infused products! Both CVS and Walgreens are focused on launching sales of topical products that have cannabidiol as an inactive ingredient.

This is exactly what Blaine Labs specializes in and can do better than anyone else! AHG will be the world's first company producing medical and pharmaceutical grade CBD-infused topicals that are registered with the FDA! AHG is undoubtedly the most perfectly positioned publicly traded CBD company - and its market cap is still below CAD$50 million!

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA is receiving compensation from AHG of USD$40,000 cash for a one-month marketing contract. Never make investment decisions based on anything NIA says. This message is meant for informational and educational purposes only and does not provide investment advice.